Joyce Suhy

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

Stephen Salloway, Spyros Chalkias, Frederik Barkhof et al. · JAMA Neurology · 2021 · 584 citations · Full text

Medicine, Neurology, Pharmacology +16

Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)

Paul Aisen, Serge Gauthier, Steven H. Ferris et al. · Archives of Medical Science · 2011 · 286 citations · Full text

Medicine, Neurology, Pharmacology +17

Standardization of analysis sets for reporting results from ADNI MRI data

Bradley T. Wyman, Danielle Harvey, Karen Crawford et al. · Alzheimer s & Dementia · 2012 · 237 citations · Full text

Medicine, Neuroscience, Radiology +16

Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease

Clifford R. Jack, Frederik Barkhof, Matt A. Bernstein et al. · Alzheimer s & Dementia · 2011 · 219 citations

Medicine, Neurology, Neuroscience +17

Effect of tramiprosate in patients with mild-to-moderate alzheimer's disease: Exploratory analyses of the MRI sub-group of the alphase study

Serge Gauthier, Paul Aisen, Steven H. Ferris et al. · The journal of nutrition health & aging · 2009 · 133 citations · Full text

Medicine, Neurology, Neuroscience +13